HSD42 Performance Assessment of a Disease-Agnostic Treatment Sequencing Heuristic for Deriving Line of Therapy (LOT) in a Real-World, Rare, Multi-Tumor Cohort across Tumor Mutational Burden (TMB) Status
Abstract
Authors
L Bouzit M Burugupalli T Snow BT Kerr N Shankar K Andrus A Afghahi C Cho-Phan